Dr. Nirmal Raut

Dr. Nirmal Raut is a distinguished Consultant Medical Oncologist with over two decades of experience in oncology practice, research, and clinical trials. He completed his MBBS from Seth G.S. Medical College, Mumbai, followed by MD in Radiation Oncology and Senior Residency in Medical Oncology at Tata Memorial Hospital. He further enhanced his expertise with a Masters in Molecular Oncology and the European Certification of Medical Oncology from CNIO with the European School of Oncology (Spain). Dr. Raut also holds a Professional Diploma in Clinical Research from Catalyst Clinical Services, New Delhi.

Dr. Raut has been actively involved in Phase III clinical trials for breast cancer, lung cancer, lymphoma, and multiple myeloma. His research has contributed to the advancement of novel therapies including Rituximab, paclitaxel, temozolomide, and lung cancer vaccines.

• Endoxifen in ER+/PR+/Her2-negative metastatic breast cancer.

• Ribociclib with letrozole as adjuvant hormonal therapy in high-risk breast cancer.

• Selinexor with bortezomib and dexamethasone in relapsed multiple myeloma

• Neoadjuvant Chemotherapy in Breast Cancer – What Have We Learned So Far – Indian Journal of Medical and Paediatric Oncology (2010).

• First Line Gefitinib in Advanced Carcinoma of Lung – A Prospective Study of 490 Patients in India (2010).

• Concurrent and Adjuvant Temozolomide with Radiotherapy in Paediatric Brainstem Glioma – International Journal of Radiation Oncology, Biology and Physics (2010).

• Contributions to Lymphoma Newsletter and Pancreatic Cancer India forum.

• Abstract presentations at international platforms including ASCO (USA), World Lung Cancer Conference (San Francisco), and Asia Pacific Lung Cancer Conference (Hyderabad).